Aneuscreen

Decision-support System for the Early Detection of Brain Aneurysms

Health Tech & Life Sciences
Active
Seed Netanya, Israel Founded 2017
Website ↗
Last updated 2026-06-18
Total raised
$1.2M
Last: 2020-08
Stage
Seed
Founded
2017
Headcount
5
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences

About

Aneuscreen brings new insights into the pathogenesis of brain aneurysms. The company has developed a revolutionary "once in a lifetime" cost-effective, and highly accurate diagnostic exam, for predicting a future formation of cerebral aneurysms using advanced computer vision (AI) techniques. The solution also detects existing aneurysms at an early stage (less than 4mm), compensating for the fact that these small instances tend to be missed by radiologists, hence saving lives, while lowering the economic burden related to the severe outcomes resulting from a rupture event (Subarachnoid hemorrhage (SAH)).

The solution acts both as a decision support tool for aneurysm detection as well as a classifier for identifying individuals who are susceptible for aneurysm development, based on morphology analysis of the brain's arterial tree. The solution can be executed on top of any neuroimaging modality that contains vascular demonstration.

Funding history · 2 rounds · $1.2M total

2020-08
2017-09
$216K

Q&A

What is Aneuscreen's primary focus?
Aneuscreen develops a decision-support system for the early detection of brain aneurysms, utilizing advanced computer vision (AI) techniques.
When was Aneuscreen founded?
Aneuscreen was founded in June 2017.
What is Aneuscreen's current employee count?
Aneuscreen has 5 employees, falling within the 1-10 employee bucket.
What is the total amount of funding Aneuscreen has raised to date?
Aneuscreen has raised a total of $1,216,000 USD.
When was Aneuscreen's last funding round and who was a lead investor?
Aneuscreen's last funding round was in August 2020, with Chaim Chizik as a lead investor.
What is Aneuscreen's current funding stage?
Aneuscreen is currently in the Seed funding stage.
What technologies does Aneuscreen utilize in its solutions?
Aneuscreen utilizes Artificial Intelligence, Deep Learning, Image Recognition, and Computer Vision in its solutions.
What are the target customer segments for Aneuscreen's solutions?
Aneuscreen targets customers in Healthcare & Life Sciences, specifically Healthcare, Insurance Companies, and Providers.
Does Aneuscreen hold any patents?
Yes, Aneuscreen holds 1 patent.

Team · 2

Founder · CEO
LinkedIn ↗
Founder · CSO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical Decision Support
Technologies
Artificial IntelligenceDeep LearningImage RecognitionComputer Vision
Target customers
Healthcare & Life SciencesHealthcareInsurance CompaniesProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

diagnosticspreventioncloud-basedmachine-visiondigital-healthcareartificial-intelligencehealth-insurancemachine-learninghealthcare-providersdecision-supporthealthcare-ithealthcarehospitalsearly-detectionbrain-disorder
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteaneuscreen.com

Identifiers & details

Founded2017-6
Employees (exact)5

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainaneuscreen.com

Certificate / subdomain footprint

Subdomains2